Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Top 3 Health Care Stocks That Are Preparing To Pump This Month

Published 18/12/2023, 12:39
© Reuters.  Top 3 Health Care Stocks That Are Preparing To Pump This Month

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

Kintara Therapeutics, Inc. (NASDAQ: KTRA)

  • On Dec. 7, Kintara Therapeutics announced a review of strategic alternatives focused on maximizing stockholder value. The company’s stock fell around 46% over the past month and has a 52-week low of $0.1650 .
  • RSI Value: 21.46
  • KTRA Price Action: Shares of Kintara Therapeutics fell 1% to close at $0.1980 on Friday.
Aadi Bioscience, Inc.
  • On Dec. 14, Aadi Bioscience released results from a planned interim analysis on the first third of participants in the ongoing tumor-agnostic PRECISION1 trial of nab-sirolimus in patients with TSC1 or TSC2 inactivating alterations.. The company’s stock fell around 54% over the past five days. It has a 52-week low of $2.25.
  • RSI Value: 23.73
  • AADI Price Action: Shares of Aadi Bioscience fell 56.4% to close at $2.34 on Friday.
DURECT Corporation
  • On Nov. 13, Durect posted downbeat sales for the third quarter. "The recently reported topline results from the AHFIRM trial showed that larsucosterol has the potential to reduce mortality in alcohol-associated hepatitis (AH) patients," stated James E. Brown, D.V.M., President and CEO of DURECT. The company’s stock fell around 9% over the past month and has a 52-week low of $0.5901.
  • RSI Value: 27.92
  • DRRX Price Action: Shares of DURECT fell 2% to close at $0.5901 on Friday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read More: Investor Sentiment Falls But Fear & Greed Index Remains In 'Greed' Zone

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.